This is a three-month, physician-supervised weight loss program built around low-dose compounded tirzepatide, given as a weekly subcutaneous injection. A licensed provider sets the dose after an online assessment, and the plan bundles monthly virtual visits, nutrition coaching and the WeightCare One app. It suits people who want a lower-dose, fully remote alternative to standard GLP-1/GIP treatment and are comfortable with a compounded product rather than brand-name Mounjaro or Zepbound. The main trade-off is that compounded tirzepatide is not FDA-approved as a finished drug and its potency can vary by pharmacy, while the low dose is not the standard weight-loss dosing used in trials.
In stockReturn policy
Rated 4.6 out of 5 across 146 ratings, the program draws mostly positive feedback for its convenience and provider support. Complaints tend to center on the compounded formulation and the modest effects of low dosing.
This is a physician-supervised online program built around small weekly doses of compounded tirzepatide. The dose is lower than standard weight loss dosing and is set by a licensed provider. The medication is prepared by a state-licensed compounding pharmacy and taken as a weekly subcutaneous injection.
The program includes monthly virtual visits with a licensed physician, personalized dosing and monitoring, and nutrition and lifestyle coaching. Members also get the WeightCare One app for progress tracking and chat with nutritionists and trainers, unlimited messaging with their provider, and a personal member success advocate. Medical support is available 24/7.
A prescription is required. You complete a free online assessment about your health history and goals, and a provider reviews it the same day. The provider decides whether treatment is appropriate. If it is prescribed, the medication is sent to your home. The assessment, visits and follow-up care all happen online, with no in-person visits required.
